The present study aims to compare the effects on glycated hemoglobin (HbA1c) at 3 months of two care models in patients with type 2 diabetes referred due to poor glycemic control: a day hospital endocrinology care model versus a care model centered on follow-up by a dietitian-nutritionist.

Inclusion Criteria:

• Patients with a diagnosis of type 2 diabetes (T2DM) referred to endocrinology due to poor metabolic control.
• Patients on insulin therapy

Exclusion Criteria:

• Referred from primary care for other reasons such as hypoglycemia.
• Patients with other types of diabetes mellitus or with uncertainty in diagnostic classification.
• Patients on rapid-acting insulin bolus therapy.
• Patients with acute decompensation of diabetes.
• Patients receiving corticosteroid treatment.
• Dependent individuals for activities of daily living (ADL) with a Barthel index score below 60 or with cognitive impairment.
• Language barrier.

Patients affected by diabetes mellitus type 2

IPD (without personal identification data) could be shared by requirement from other researchers after the end of the study, and only for research purposes and previous approval of promotor center of the study (CSAPG). Anyway, Spanish and European Union legal policy about data protection will strictly be followed (IPD will not be transferred outside European Union).

After publication of main results of the study.

IPD will be shared only for scientific research purposes and following the Spanish and European Union normative law about data protection. The requirements will be directed to the IP of the study. The IP will evaluate the request to verify and evaluate the data that is requested and the purposes for which it is requested. Next, the IP will transfer the request to the promotor center the study for the final decision.